More importantly, an increase in immunochemical-reactive MMP-2 and MT1-MMP was detected in 92% and 100% respectively, of invasive cervical cancer biopsies positive for HPV16 highlighting the involvement of HPV16 in cervical cancer progression. This evidence concerns the gene MMP2 and cervical carcinoma.